Oncolytics Biotech, Inc. (NASDAQ: ONCY)

Oncolytics Biotech, Inc. (NASDAQ: ONCY) has focused their efforts on the discovery and development of pharmaceutical products designed to treat of a broad range of human cancers. With headquarters in Calgary, Alberta, Canada, the Company was formed in 1998 to investigate the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, which happens to be one of the most common families of genetic defects leading to cancer. For further information, visit the Company’s web site at www.oncolytics.com.